14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 22, 2024 Sell 480 Hagen Brett R Common Stock
Apr 22, 2024 Sell 757 Miller Edward Common Stock
Apr 22, 2024 Sell 1 857 Sinha Vikas Common Stock
Apr 19, 2024 Sell 473 Hagen Brett R Common Stock
Apr 19, 2024 Sell 626 Miller Edward Common Stock
Apr 19, 2024 Sell 9 601 Brainard Diana Common Stock
Apr 19, 2024 Sell 1 521 Sinha Vikas Common Stock
Apr 02, 2024 Sell 368 Miller Edward Common Stock
Apr 02, 2024 Sell 1 533 Brainard Diana Common Stock
Apr 02, 2024 Sell 281 Hagen Brett R Common Stock
Apr 02, 2024 Sell 885 Sinha Vikas Common Stock
Feb 21, 2024 Sell 5 155 Brainard Diana Common Stock
Feb 20, 2024 Sell 3 097 Brainard Diana Common Stock
Feb 20, 2024 Sell 385 Miller Edward Common Stock
Feb 20, 2024 Sell 2 893 Sinha Vikas Common Stock
Feb 20, 2024 Sell 494 Hagen Brett R Common Stock
Feb 08, 2024 Sell 11 150 Hagen Brett R Common Stock
Feb 05, 2024 Sell 18 331 Sinha Vikas Common Stock
Feb 05, 2024 Sell 8 869 Miller Edward Common Stock
Feb 05, 2024 Sell 5 792 Hagen Brett R Common Stock
Feb 05, 2024 Sell 41 421 Brainard Diana Common Stock
Jan 23, 2024 Sell 3 205 Sinha Vikas Common Stock
Jan 23, 2024 Sell 9 500 Brainard Diana Common Stock
Jan 23, 2024 Sell 901 Hagen Brett R Common Stock
Jan 23, 2024 Sell 1 302 Miller Edward Common Stock
Jan 04, 2024 Sell 310 Hagen Brett R Common Stock
Jan 04, 2024 Sell 424 Miller Edward Common Stock
Jan 04, 2024 Sell 961 Sinha Vikas Common Stock
Jan 04, 2024 Sell 1 664 Brainard Diana Common Stock
Dec 27, 2023 Sell 28 335 Hagen Brett R Common Stock
Nov 20, 2023 Sell 4 382 Brainard Diana Common Stock
Nov 17, 2023 Sell 2 490 Sinha Vikas Common Stock
Nov 17, 2023 Sell 2 689 Brainard Diana Common Stock
Nov 17, 2023 Sell 403 Hagen Brett R Common Stock
Oct 20, 2023 Sell 357 Hagen Brett R Common Stock
Oct 20, 2023 Sell 1 475 Sinha Vikas Common Stock
Oct 19, 2023 Sell 358 Hagen Brett R Common Stock
Oct 19, 2023 Sell 1 232 Sinha Vikas Common Stock
Oct 19, 2023 Sell 8 581 Brainard Diana Common Stock
Oct 03, 2023 Sell 1 325 Brainard Diana Common Stock
Oct 03, 2023 Sell 755 Sinha Vikas Common Stock
Oct 03, 2023 Sell 222 Hagen Brett R Common Stock
Aug 18, 2023 Sell 4 055 Brainard Diana Common Stock
Aug 17, 2023 Sell 10 516 Sinha Vikas Common Stock
Aug 17, 2023 Sell 11 361 Brainard Diana Common Stock
Aug 17, 2023 Sell 1 653 Hagen Brett R Common Stock
Jul 20, 2023 Sell 342 Hagen Brett R Common Stock
Jul 20, 2023 Sell 1 437 Sinha Vikas Common Stock
Jul 19, 2023 Sell 8 342 Brainard Diana Common Stock
Jul 19, 2023 Sell 342 Hagen Brett R Common Stock
Jul 19, 2023 Sell 1 198 Sinha Vikas Common Stock
Jul 05, 2023 Sell 5 275 Brainard Diana Common Stock
Jul 05, 2023 Sell 2 983 Sinha Vikas Common Stock
Jul 03, 2023 Buy 273 000 Piccina Cintia Stock Option (Right to Buy)
Jul 03, 2023 Buy 147 000 Piccina Cintia Common Stock
Jun 27, 2023 Buy 2 930 870 Gilead Sciences, Inc. Common Stock
Jun 12, 2023 Buy 0 Piccina Cintia
Jun 09, 2023 Sell 5 045 Hagen Brett R Common Stock
May 18, 2023 Sell 4 536 Brainard Diana Common Stock
May 11, 2023 Buy 35 000 Adams Derek N. Common Stock
May 11, 2023 Buy 35 000 Vera Juan Common Stock
May 11, 2023 Buy 35 000 Bornstein Jeffrey S Common Stock
May 11, 2023 Buy 35 000 Brenner Malcolm Common Stock
May 11, 2023 Buy 35 000 Hallal David Common Stock
May 11, 2023 Buy 35 000 Jovan-embiricos Morana Common Stock
May 11, 2023 Buy 35 000 Tomasello Shawn Common Stock
Apr 20, 2023 Sell 1 466 Sinha Vikas Common Stock
Apr 20, 2023 Sell 349 Hagen Brett R Common Stock
Apr 19, 2023 Sell 1 217 Sinha Vikas Common Stock
Apr 19, 2023 Sell 348 Hagen Brett R Common Stock
Apr 19, 2023 Sell 8 408 Brainard Diana Common Stock
Mar 01, 2023 Buy 45 000 Adams Derek N. Stock Option (Right to Buy)
Mar 01, 2023 Buy 0 Adams Derek N.
Feb 21, 2023 Sell 5 122 Brainard Diana Common Stock
Feb 02, 2023 Buy 157 500 Sinha Vikas Common Stock
Feb 02, 2023 Buy 292 500 Sinha Vikas Stock Option (Right to Buy)
Feb 02, 2023 Buy 162 500 Miller Edward Stock Option (Right to Buy)
Feb 02, 2023 Buy 81 250 Leen Ann M. Stock Option (Right to Buy)
Feb 02, 2023 Buy 87 500 Miller Edward Common Stock
Feb 02, 2023 Buy 43 750 Leen Ann M. Common Stock
Feb 02, 2023 Buy 113 750 Hagen Brett R Stock Option (Right to Buy)
Feb 02, 2023 Buy 61 250 Hagen Brett R Common Stock
Feb 02, 2023 Buy 617 500 Brainard Diana Stock Option (Right to Buy)
Feb 02, 2023 Buy 332 500 Brainard Diana Common Stock
Jan 20, 2023 Sell 1 426 Sinha Vikas Common Stock
Jan 20, 2023 Sell 541 Miller Edward Common Stock
Jan 20, 2023 Sell 338 Hagen Brett R Common Stock
Jan 19, 2023 Sell 5 111 Sinha Vikas Common Stock
Jan 19, 2023 Sell 2 032 Miller Edward Common Stock
Jan 19, 2023 Sell 1 557 Hagen Brett R Common Stock
Jan 19, 2023 Sell 34 435 Brainard Diana Common Stock
Dec 02, 2022 Buy 98 346 Miller Edward Common Stock
Dec 02, 2022 Sell 98 346 Miller Edward Common Stock
Nov 18, 2022 Sell 4 515 Brainard Diana Common Stock
Nov 16, 2022 Sell 16 074 Van Beek Jeroen B Common Stock
Nov 14, 2022 Sell 2 358 Miller Edward Common Stock
Jul 01, 2022 Buy 26 000 Leen Ann M. Stock Option (Right to Buy)
Jul 01, 2022 Buy 14 000 Leen Ann M. Common Stock
Jan 18, 2022 Buy 56 744 Leen Ann M. Stock Option (Right to Buy)
Jan 18, 2022 Buy 23 256 Leen Ann M. Common Stock
INSIDER POWER
82.469
Last 100 transactions
Buy: 5 809 216 | Sell: 427 568 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 82.469.

In total, the insiders bought 5 809 216 and sold 427 568 ALVR shares in the last 100 trades.

Click to get the best stock tips daily for free!

About AlloVir, Inc.

AlloVir. Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical develop... ALVR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT